Motor Neuron Disease (MND), which includes Amyotrophic Lateral Sclerosis (ALS), is a progressive neurological condition in which the nerve cells controlling voluntary muscle movement gradually degenerate, leading to increasing weakness, muscle wasting, and, over time, difficulties with speech, swallowing, and breathing. There is currently no treatment that stops or reverses this degeneration, and standard neurology care focuses on slowing progression where possible, managing symptoms, and supporting quality of life through a multidisciplinary team. Many patients and families from Pakistan travel to India seeking a specialist second opinion and to understand whether stem cell therapy has any role to play alongside their existing neurology care.
MND/ALS has no cure, and disease-modifying drug options remain limited worldwide, including in Pakistan, where access to specialist neuromuscular clinics and multidisciplinary MND care can be limited outside a few large cities. Patients and families who want to explore every reasonable avenue alongside their existing treatment sometimes seek an evaluation for regenerative approaches such as stem cell therapy, in addition to ongoing neurology follow-up.
Dr. Tyagi leads regenerative medicine protocol design at Stem Cell Cure India, overseeing stem cell sourcing, lab processing, and treatment planning for patients being evaluated for Motor Neuron Disease and other neuro-regenerative conditions.
Dr. Singh brings over three decades of clinical experience in general medicine and surgery, supporting the overall health evaluation of patients travelling from Pakistan before and during their stem cell therapy journey.
Mesenchymal Stem Cells (MSCs) are being studied for their potential neuroprotective and anti-inflammatory effects, and for a possible supportive role in slowing certain aspects of motor neuron degeneration in some research settings. It is important to set realistic expectations: stem cell therapy is not currently established as a treatment that halts or reverses MND/ALS, and motor neurons already lost are not known to regenerate with this or any other available treatment. This approach is explored as a complement to — not a replacement for — standard neurology care, including disease-modifying medication, respiratory support, and multidisciplinary symptom management.
Suitability depends on the specific type of MND, how far the disease has progressed, and current respiratory and swallowing function. Before travelling from Pakistan, our team reviews:
No. MND, including ALS, involves progressive degeneration of motor neurons, and stem cell therapy does not stop or reverse this process. It is explored as an option that may offer supportive benefit alongside standard neurology care and multidisciplinary management — it is not a cure.
This depends on the subtype of MND, how long ago symptoms began, current muscle strength and breathing function, and ongoing treatments such as riluzole. Please share your neurology reports so our team can give an initial opinion.
Recent neurology consultation notes, EMG/nerve conduction study results, MRI of the brain and spine where done, current medication list, and a note on breathing (respiratory) function.
Most patients stay between 7 and 10 days, depending on the diagnostic work-up and treatment plan required.
Yes. Once an evaluation is confirmed, we provide the invitation letter and supporting documents needed to apply for an Indian Medical Visa, and guide you through each step.
Cost depends on the specific condition, its severity, and the plan required. Contact us for a personalised quote after sharing your reports and medical history.
Source: These are real, verified Google reviews currently published on stemcellcure.in — pulled from our Google Business Profile (5.0★, 33+ reviews).
Contact Stem Cell Cure India today to share your medical history and get a personalised opinion on suitability.
